Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China · Delayed Price · Currency is CNY 6.80
-0.01 (-0.15%)
Sep 30, 2025, 3:00 PM CST
SHA:603718 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 273.14 | 271.02 | 231.35 | 294.12 | 346.15 | 258.32 | Upgrade |
Other Revenue | 0.08 | 0.02 | 9.37 | 5.87 | 1.14 | 0.8 | Upgrade |
| 273.22 | 271.04 | 240.72 | 299.99 | 347.29 | 259.13 | Upgrade | |
Revenue Growth (YoY) | 19.09% | 12.59% | -19.76% | -13.62% | 34.02% | -6.79% | Upgrade |
Cost of Revenue | 79.33 | 110.39 | 120.3 | 124.61 | 158.4 | 140.2 | Upgrade |
Gross Profit | 193.89 | 160.65 | 120.42 | 175.38 | 188.89 | 118.93 | Upgrade |
Selling, General & Admin | 91.17 | 111.95 | 99.77 | 126.85 | 129.9 | 118.23 | Upgrade |
Research & Development | 25.22 | 24.45 | 24.97 | 29.94 | 28.64 | 29.53 | Upgrade |
Other Operating Expenses | 4.66 | 2.17 | 1.4 | 3.33 | 3.5 | 2.27 | Upgrade |
Operating Expenses | 125.42 | 142.12 | 126.92 | 159.69 | 166.99 | 156.29 | Upgrade |
Operating Income | 68.47 | 18.53 | -6.5 | 15.69 | 21.9 | -37.36 | Upgrade |
Interest Expense | -3.65 | -5.49 | -5.39 | -10.31 | -12.38 | -17.69 | Upgrade |
Interest & Investment Income | 160.44 | 160.61 | 75.82 | 16.43 | 27.79 | 23.61 | Upgrade |
Currency Exchange Gain (Loss) | 9.6 | 10.3 | -0.01 | -0.06 | 0.28 | 1.3 | Upgrade |
Other Non Operating Income (Expenses) | -34.85 | -0.4 | -0.29 | 1.38 | -1.61 | -0.14 | Upgrade |
EBT Excluding Unusual Items | 200.01 | 183.55 | 63.63 | 23.14 | 35.99 | -30.28 | Upgrade |
Impairment of Goodwill | -1.19 | -1.19 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -10.74 | -12.76 | -16.52 | -2.97 | 8.28 | 1.62 | Upgrade |
Gain (Loss) on Sale of Assets | -0.49 | -0.71 | 0.55 | -0.36 | 7.41 | -2.78 | Upgrade |
Other Unusual Items | 40.63 | 39.22 | 8.36 | 111.41 | 5.46 | 8.09 | Upgrade |
Pretax Income | 228.23 | 208.12 | 56.02 | 131.22 | 57.14 | -23.34 | Upgrade |
Income Tax Expense | 24.99 | 26.48 | 6.01 | 20.53 | 11.47 | 8.81 | Upgrade |
Earnings From Continuing Operations | 203.24 | 181.64 | 50.01 | 110.69 | 45.67 | -32.15 | Upgrade |
Minority Interest in Earnings | -28.95 | -10.46 | 12.86 | 10.92 | 8.19 | 41.08 | Upgrade |
Net Income | 174.29 | 171.18 | 62.87 | 121.61 | 53.86 | 8.93 | Upgrade |
Net Income to Common | 174.29 | 171.18 | 62.87 | 121.61 | 53.86 | 8.93 | Upgrade |
Net Income Growth | - | 172.28% | -48.30% | 125.80% | 503.33% | -26.54% | Upgrade |
Shares Outstanding (Basic) | 634 | 634 | 629 | 640 | 673 | 893 | Upgrade |
Shares Outstanding (Diluted) | 658 | 658 | 629 | 640 | 673 | 893 | Upgrade |
Shares Change (YoY) | 4.55% | 4.72% | -1.77% | -4.93% | -24.58% | 46.92% | Upgrade |
EPS (Basic) | 0.27 | 0.27 | 0.10 | 0.19 | 0.08 | 0.01 | Upgrade |
EPS (Diluted) | 0.26 | 0.26 | 0.10 | 0.19 | 0.08 | 0.01 | Upgrade |
EPS Growth | - | 160.00% | -47.37% | 137.50% | 700.00% | -50.00% | Upgrade |
Free Cash Flow | 64.14 | 38.08 | -16.18 | 273.06 | 5.85 | 133.56 | Upgrade |
Free Cash Flow Per Share | 0.10 | 0.06 | -0.03 | 0.43 | 0.01 | 0.15 | Upgrade |
Dividend Per Share | 0.078 | 0.078 | 0.029 | 0.057 | - | 0.004 | Upgrade |
Dividend Growth | 173.17% | 173.17% | -49.38% | - | - | -30.00% | Upgrade |
Gross Margin | 70.97% | 59.27% | 50.02% | 58.46% | 54.39% | 45.90% | Upgrade |
Operating Margin | 25.06% | 6.84% | -2.70% | 5.23% | 6.30% | -14.42% | Upgrade |
Profit Margin | 63.79% | 63.16% | 26.12% | 40.54% | 15.51% | 3.45% | Upgrade |
Free Cash Flow Margin | 23.48% | 14.05% | -6.72% | 91.02% | 1.69% | 51.54% | Upgrade |
EBITDA | 92.21 | 53.27 | 29.16 | 56.86 | 78.79 | 20.86 | Upgrade |
EBITDA Margin | 33.75% | 19.65% | 12.11% | 18.95% | 22.69% | 8.05% | Upgrade |
D&A For EBITDA | 23.74 | 34.74 | 35.66 | 41.17 | 56.9 | 58.22 | Upgrade |
EBIT | 68.47 | 18.53 | -6.5 | 15.69 | 21.9 | -37.36 | Upgrade |
EBIT Margin | 25.06% | 6.84% | -2.70% | 5.23% | 6.30% | -14.42% | Upgrade |
Effective Tax Rate | 10.95% | 12.72% | 10.73% | 15.64% | 20.08% | - | Upgrade |
Revenue as Reported | 273.22 | 271.04 | 240.72 | 299.99 | 347.29 | 259.13 | Upgrade |
Advertising Expenses | - | 3.81 | 3.22 | 3.67 | 3.73 | 8.4 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.